Alternatives to SPRING Biomed Vision

Alcon is a global leader in eye care, providing a broad portfolio of products to enhance sight and improve lives.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Develops technology for early detection and tracking of diseases like Alzheimer's and AMD through non-invasive eye exams.

AI-powered diagnostic platform detecting and interpreting inaccessible body infra-sounds for enhanced medical diagnosis.

Liger Medical develops breakthrough optical diagnostic devices and software for early cancer detection and other medical purposes.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Developing the first robotic surgery platform for cataracts and widespread eye diseases.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Zsquare develops the world's thinnest, high-resolution micro-endoscopes for various medical applications, enabling disposable and cost-effective procedures.

AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.

Clinical reasoning AI engine for scalable, high-value healthcare intake and assessment.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Developing CORA, a smart exam for early detection of coronary artery disease.

MedTech company developing a remote monitoring solution for Congestive Heart Failure patients.

AI and eye-tracking platform for early detection and treatment of pediatric vision loss.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

ART Medical develops the smART+ Platform, an ecosystem of software and sensor-based tools to detect, predict, and prevent ICU-acquired complications.